[WEBINAR] Novel Strategies to Transform the Pace and Cost of High-Potency API Development
Highly potent active pharmaceutical ingredients (HPAPIs) have garnered increasing attention within the pharmaceutical development landscape. There are currently >1,000 highly potent candidates in various stages of R&D, with an anticipated annual growth rate of approximately 10% in this field.
Nonetheless, the handling of HPAPIs demands stringent operational procedures that typically necessitate substantial capital investment and specialized personnel for development, resulting in a decelerated progress.
In this webinar, Guangyang Hou, a Senior Process Development Engineer at APC, explores how model-supported approaches in conjunction with the implementation of Process Analytical Technologies (PAT) and continuous processing, can minimize human intervention whilst drastically reducing development times.
In particular he explores:
Why HPAPI process development does not always mean longer development timelines.
How to implement digital twins and PAT to safely and quickly gain valuable process insights.
How a judicious choice of batch versus continuous processing can be applied to overcome key operational handling challenges.